Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Newsletter

Tuesday, 14th December 2021

by Sumit Chanda
December 14, 2021
in Newsletter
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

Retail inflation for November touched a 3-month high of 4.91% due to a spike in food prices. However, the CPI inflation remains within the upper limit of 6% prescribed by the RBI for inflation. The inflation was at 4.48% in the month of October. With the Centre and state reducing taxes on petrol and diesel, fuel was lower on a sequential basis. While this figure is better than the 5.10% projected by economists in a Reuters poll, it is still much higher than the median expected rate of inflation. It is likely to impact RBI policy.

Emcure Pharma, backed by Bain Capital, got SEBI approval for its proposed IPO. The IPO will comprise of a fresh issue of Rs.1,100 crore and OFS of 181.68 lakh shares by promoters and early investors. Emcure is evaluating a pre-IPO placement of Rs.200 crore, in which case the IPO size will be cut proportionately. Emcure Pharma develops, manufactures and globally markets a broad range of pharmaceutical products with presence in 70 markets globally. Emcure Pharma is currently developing RNA vaccine for COVID-19.

Data Patterns India, solution provider to defence and aerospace sector, garnered Rs.176.46 crore from 23 anchor investors a day before the opening of its IPO. The IPO of Data Patterns will be open from 14-Dec to 16-Dec. It will allocate 30,16,533 shares to anchor investors at the upper price band of Rs.585. Some of the key anchor investors included Axis MF, Ashoka India Fund, HDFC MF, ICICI Prudential MF, Nippon Life AMC, Kotak Mutual, IIFL Focused Equity Fund, Tata Mutual Fund, HDFC Life, Volrado Venture and Nomura.

Apple may already be the most valuable stock in the world by a margin, but it continues to create value. For example, Apple stock price is just $2 short of the Apple market cap crossing $3 trillion for the first time. Apple stock has rallied nearly 11% in the last four sessions. The stock has been robust this year after the stellar response to its latest iPhone model. Currently, Apple and Microsoft are the only 2 companies in the $2 trillion club while Amazon, Google and Tesla are above $1 trillion. NVidia is closing in rapidly. 

Shriram Capital and Shriram City Union Finance will merge with Shriram Transport Finance as part of the overall group restructuring. The combined entity will be christened Shriram Finance Ltd. The combined entity will have overall AUM in excess of Rs.1.50 trillion and a distribution network of over 3,500. It will be a stock swap deal so Shriram Transport will issue 1.55 shares for every one share of SCUF and 0.097 shares for every one share of Shriram Capital. Shareholder and regulatory approvals are still pending.

PB Fintech, which owns and operates the Policybazaar and Paisabazaar platforms, hit a new low of Rs.1,085.90 on 13th December. The stock has fallen below its previous low and is now inching closer to its IPO price of Rs.950. PB Fintech was valued at 46 times Sales, which is quite steep. The focus of PB Fintech will now be on expanding the customer base and addressing the under-penetration of insurance in India. The issue was well received by the market and was subscribed more than 15 times in the IPO.

One of the biggest benchmarks in global bond and loan pricing, the LIBOR, will come to an end as on 31-December. London Interbank Offer Rate (LIBOR) had been a bone of contention after the regulators had imposed huge penalties on banks for rigging the LIBOR for unfair gains. However, the immediate challenge is that nearly $265 trillion of bonds and debt are linked to the LIBOR. Banks have already spent $10 billion preparing for the demise of LIBOR and are also exploring other alternatives to fill up the gap in benchmark.

Paytm may have had problems with its stock price performance post listing, but the stock continues to see robust financial numbers. For October and November, Paytm reported $22.4 billion, or Rs.1.66 trillion of gross merchandise value or GMV, on the Paytm platform. This is 129% higher than the corresponding period last year. Paytm had reported GMV of Rs.1.95 trillion for Sep-21 quarter. Paytm deployed a total of 16 lakh devices Nov-21. Paytm stock has been under a lot of pressure as weak hands are moving out. 

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Related Posts

Illustration of bullish and bearish market trends with digital bull and bear icons standing on stacked gold coins, promoting 6 multibagger stocks that surged in 2025. "Is your portfolio still in 2022?" – Jarvis AI

These 6 Multibagger Stocks Exploded in 2025 — Is Your Portfolio Still in 2022?

by Sumit Chanda
June 26, 2025
0
5.3k

In 2025, six multibagger stocks delivered explosive returns—while many investors were still stuck with outdated portfolios. Are you missing the...

Jarvis Invest blog - ‘Liquidity or Inflation? RBI Policy June 2025’ reflecting monetary policy focus

Liquidity or Inflation? RBI Policy June 2025

by Sumit Chanda
June 6, 2025
0
10

On June 6, 2025, the Reserve Bank of India took a bold step to revive economic momentum by slashing both...

Gold vs Stocks: Where should indians invest for better returns?

Gold vs Stocks: Where should Indians invest for better returns?

by Sumit Chanda
May 30, 2025
0
5.3k

As the world’s investment landscape shifts, investors often face the dilemma of where to park their funds for optimal returns....

NRI Investment Plan in India

How can NRIs invest Rs 50 lakh in India?

by Sumit Chanda
May 23, 2025
0
5.3k

When it comes to investment in India, Non-resident Indians (NRIs) are always skeptical about where to invest their hard-earned money....

Top 5 best growth stocks in India and sectors to watch in 2025

Top 5 Best Growth Stocks in India & Sectors to Watch in 2025

by Sumit Chanda
May 8, 2025
0
5.5k

You see the market correction in late 2024 and early 2025 was driven by weak economic data, corporate earnings misses,...

Best sectors to invest in 2025

India’s Fastest-Growing & Best sectors to invest in 2025

by Sumit Chanda
April 29, 2025
0
5.6k

In this blog, we are going to delve into the best sectors to invest in 2025 anticipated to experience the...

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Equity Market
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Interesting Read
  • Financial Planning
  • Portfolio Management
  • Newsletter
Connect with us: customersupport@jarvisinvest.com

© 2023 Jarvis Invest

No Result
View All Result
  • CATEGORIES
    • Equity Market
    • Investing Basics
    • Interesting Read
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Newsletter
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version